Polygon Management »

Monte Rosa Therapeutics shares owned by Polygon Management

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Polygon Management from 13F filings

Historical chart of Polygon Management investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by Polygon Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by Polygon Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.4M 56k 24.20

More positions owned by Polygon Management

Uipath Cl A (PATH)
Kolibri Global Energy Com New (KGEI)
Autolus Therapeutics Spon Ads (AUTL)
Lyft Cl A Com (LYFT)
Definium Therapeutics Com Shs (DFTX)
Workiva Com Cl A (WK)
Silence Therapeutics Ads Call Option (SLN)
Sprinklr Cl A (CXM)
Mbx Biosciences (MBX)
Alkami Technology (ALKT)
Celldex Therapeutics Com New (CLDX)
Relay Therapeutics (RLAY)
Arrowhead Pharmaceuticals (ARWR)
Pharvaris N V (PHVS)
Alkermes SHS (ALKS)

View all positions for Polygon Management

Top funds holding Monte Rosa Therapeutics

NEA Management Company
BlackRock
T. Rowe Price Associates
TCG Crossover Management
Vestal Point Capital
BVF
Baker Bros. Advisors
Suvretta Capital Management
Vanguard Capital Management
State Street Corporation
Versant Venture Management
Braidwell
Geode Capital Management
American Century Companies
Marshall Wace

View all funds holding Monte Rosa Therapeutics